Internal Medicine, Rheumatology · Albuquerque, NM
NPI
1689713679
Since 2007
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
3820 Masthead St NE
Albuquerque, NM, 87109
Phone (505) 205-1313
Groups this clinician bills Medicare through
Medicare paid, 2024
$738K
173,102 services
Medicare patients, 2024
321
Average age 74
Drug cost, 2024
$2.1M
2,389 prescriptions
Company payments, 2025
$971
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Andres Peisajovich was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 170,000 times for 41 patients. In total Andres Peisajovich billed 173,102 services in 15 codes, and Medicare paid $738K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-06-20.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 170,000 | 41 | $3.61 | $613K |
| 96401 Chemotherapy Administration | Office | 850 | 41 | $52.21 | $44K |
| 99214 Office E&M - Established | Office | 755 | 303 | $82.17 | $62K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 166 | 135 | $12.15 | $2,018 |
| 99204 Office E&M - New | Office | 51 | 51 | $117.42 | $5,989 |
| 99215 Office E&M - Established | Office | 38 | 33 | $133.54 | $5,075 |
| 20610 Joint Injection | Office | 35 | 13 | $48.40 | $1,694 |
| 99205 Office E&M - New | Office | 18 | 18 | $152.79 | $2,750 |
By year: 2022 $723K for 137,757 services; 2023 $671K for 145,723 services; 2024 $738K for 173,102 services.
Medicare prescription drug claims, 2024
In 2024, the drug Andres Peisajovich prescribed most often to Medicare patients was Prednisone, with 660 prescriptions and refills. In total Andres Peisajovich wrote 2,389 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 660 | 1,570 | 246 | $7,852 |
| Methotrexate Methotrexate Sodium | 496 | 1,218 | 133 | $16K |
| Hydroxychloroquine Sulfate Generic | 233 | 661 | 77 | $9,360 |
| Allopurinol Generic | 171 | 501 | 53 | $3,023 |
| Leflunomide Generic | 114 | 291 | 35 | $9,857 |
| Xeljanz Xr Tofacitinib Citrate | 77 | 83 | Under 11 | $497K |
| Tizanidine Hcl Generic | 55 | 110 | 25 | $788 |
| Folic Acid Generic | 52 | 157 | 18 | $568 |
| Alendronate Sodium Generic | 48 | 118 | 18 | $658 |
| Probenecid Generic | 36 | 100 | 11 | $6,852 |
| Sulfasalazine Generic | 34 | 94 | 12 | $1,729 |
| Humira(Cf) Pen Adalimumab | 32 | 41 | Under 11 | $283K |
| Enbrel Sureclick Etanercept | 30 | 39 | Under 11 | $312K |
| Amjevita(Cf) Autoinjector Adalimumab-Atto | 30 | 30 | Under 11 | $90K |
| Azathioprine Generic | 29 | 80 | 12 | $3,797 |
Brand drugs: - claims; generic drugs: 2,062 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Andres Peisajovich $971 ($971 in general payments such as food, travel and fees) from 7 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $289.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.